Partner Gabor Garai was quoted in an article that appeared in the Boston Globe on May 10, 2013 titled, “Markets draw life science start-ups.” The article discussed how rebounding financial markets are attracting an increasing number of life sciences start-ups looking to raise large amounts of money through IPOs — resulting in the anticipated biggest coming-out class for life sciences since 2007. The article highlighted the risks to going public, but noted that public offerings are emerging as the financing event of choice for start-ups that do not want to give up too much control to private investors or larger industry players. Mr. Garai was quoted as saying, “When it comes to drugs, the cost of getting anything to market has become inordinate. Right now, there’s more money in the public markets chasing deals than in the venture capital markets. We’re seeing the first signs of spring after a cold winter for IPOs.”
People
Related News
July 11, 2025
In the News
Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies
Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."
July 11, 2025
In the News
David Morris Featured for Arrival to Foley's Salt Lake City Office
Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.
July 10, 2025
In the News
Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment
Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."